# Bram Verstockt

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bram-verstockt/

## Facts

| Field | Value |
| --- | --- |
| Citations | 13,526 |
| Field | Inflammatory Bowel Disease |
| h-index | 49 |
| i10-index | 127 |
| Last Known Institution | Universitair Ziekenhuis Leuven |
| OpenAlex ID | https://openalex.org/A5036654221 |
| ORCID iD | 0000-0003-3898-7093 |
| Works | 577 |

## Researcher papers

- [ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications](https://scholariq.org/papers/ecco-esgar-guideline-for-diagnostic-assessment-in-ibd-part-1-initial-diagnosis/)
- [ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-medical-treatment/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-surgical-treatment/)
- [ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-ulcerative-colitis-medical-treatment/)
- [ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-ulcerative-colitis-surgical-treatment/)
- [ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease](https://scholariq.org/papers/ecco-guidelines-on-the-prevention-diagnosis-and-management-of-infections-in/)
- [ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects](https://scholariq.org/papers/ecco-esgar-guideline-for-diagnostic-assessment-in-ibd-part-2-ibd-scores-and/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-medical-treatment-2/)
- [IL-12 and IL-23 pathway inhibition in inflammatory bowel disease](https://scholariq.org/papers/il-12-and-il-23-pathway-inhibition-in-inflammatory-bowel-disease/)
- [Big data in IBD: big progress for clinical practice](https://scholariq.org/papers/big-data-in-ibd-big-progress-for-clinical-practice/)
- [No Increased Risk of Venous Thromboembolism or Infectious Complications after Janus Kinase Inhibitor Exposure in Patients with Ulcerative Colitis Undergoing Surgery](https://scholariq.org/papers/no-increased-risk-of-venous-thromboembolism-or-infectious-complications-after/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)

## Researcher university

- [Universitair Ziekenhuis Leuven](https://scholariq.org/institutions/universitair-ziekenhuis-leuven/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.